View drug registration information details.
Items | Registration information |
ID | 321 |
No | 321 |
Brand Name | HOVID TENOFOVIR DISOPROXIL FUMARATE TABLETS 300 MG |
Ingredients | TENOFOVIR DISOPROXIL FUMARATE 300 MG |
Dosage Form | FILM COATED TABLET |
Primary Packaging | BOTTLE |
Storage | STORE BELOW 30C |
Shelf Life | 3 YEARS |
Pack Size | BOX OF 30'S |
Dispensing Category | Prescription only |
ATC Classification | |
Pharmaceutical Class | ANTIVIRAL |
Indications | FOR THE TREATMENT OF HIV-1 INFECTION IN COMBINATION WITH OTHER ANTIRETROVIRAL MEDICINAL PRODUCT FOR ADULTS, TREATMENT OF HIV-1 INFECTED ADOLESCENTS WITH NRTI RESISITANCE OR TOXICITIES PRECLUDING THE USE OF FIRST LINE AGENTS, AGED 12 TO <18 YEARS, FORO THE TREATMENT OF CHRONIC HEPATITIS B IN ADULT AND ADOLESCENT 12 - <18 YEARS OF AGE. |
Contraindications | HYPERSENSITIVITY |
Side Effects | HYPOPHOSPHATAEMIA, DIZZINESS, HEADACHE, DIARRHEA, VOMITING, NAUSEA, ABDOMINAL PAIN, ABDOMINAL DISTENSION, FLATULENCE, INCREASED TRANSAMINASES, RASH, ASTHENIA |
Unit Price | |
EDL |
Yes |
Description | WHITE, OBLONG, FILM COATED TABLET, EMBOSSED WITH QZ ON BOTH SIDES OF TABLETS |
Note | |
License Owner | BMS PHARMA SOLE CO.,LTD |
Manufacturer | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO.,LTD |
Country | CHINA |
Import Registration No | GYZZ H20173303 |
Import Registration Date | 39-09-2017 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2021-09-07 |
FDD Registration No | 01 I 5391/23 |
FDD Registration Date | 2023-01-23 |
Expiry Date | 2026-01-22 |
Back to drug list
|